Bioxcel Therapeutics, INC. (BTAI) — SC 13D/A Filings
All SC 13D/A filings from Bioxcel Therapeutics, INC.. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (1)
-
BioXcel Holdings & Vimal Mehta Amend 13D Filing
— Jun 6, 2024 Risk: medium
On June 6, 2024, BioXcel Holdings, Inc. and Vimal Mehta filed an amendment (Amendment No. 1) to their Schedule 13D for BioXcel Therapeutics, Inc. The filing ind
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX